Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo

HIGHLIGHTS

• who: Ziruizhuo Zhang from the Hokkaido University, Japan have published the article: Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo, in the Journal: (JOURNAL)
• what: Specifically, the authors demonstrate that Mzb sensitizes cervical cancer cells to the cytotoxic effect of CDDP by upregulating Ang-1 and downregulating the expression of SCF, Flt-3L and Tie-2. The data support the model described in Figure 8.
• how: Following the completion of CCK-8 assays the data were analyzed and combination indices . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.